Debut Plus

₹6.19

▼ -0.11 -1.75%

As of 10 Sept 2026 · delayed

BSE Listed · Pharmaceuticals

IBC
What does IBC mean?
BSE · Securities under IBCThe company is in the insolvency process. Practical meaning: equity holders often recover little or nothing in resolution, so the exchange restricts price movement to stop speculative churn in a claim that may be extinguished.Criteria: Company admitted to the Corporate Insolvency Resolution Process under the Insolvency & Bankruptcy Code; placed under surveillance with restricted price movement.Exchange notice · 2026-04-21

Vivimed Labs Ltd. (532660)

Volume: 16,925Avg Vol 1W: 7,303Avg Vol 1M: 23,42452W Range:₹4.76₹27.99
BSE www.vivimedlabs.com AI Report
Key Ratios
Checked 7h ago
Market Cap₹51 Cr
Current Price₹6.19
Previous Close₹6.3
High / Low (52w)₹27.99 / ₹4.76
Volume16,925
Avg Vol (1W)7,303
Avg Vol (1M)23,424
Stock P/E—
Book Value₹-29.98
Dividend Yield0%
ROE83.81%
ROA-23.42%
Revenue (TTM)—
Revenue Growth-22%
Profit Margin-252.12%
Total Debt₹64 Cr
Shares Outstanding8 Cr
Face Value₹2
EPS (TTM)₹0
P/B—
Debt / Equity0
50 DMA₹5.68
200 DMA—
Day change-1.75%
SurveillanceIBC
Price Chart
₹6.19▼ 76.65% · 1Y
₹27₹59.4L
2025-12-18
2026-09-10

20-day avg volume: 19K shares

Pros
  • Healthy return on equity of 83.8%.
  • Company is almost debt-free.
Cons
  • Revenue fell 35% YoY.
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹29 Cr₹25 Cr₹37 Cr₹26 Cr₹21 Cr₹21 Cr₹16 Cr₹12 Cr
EBITDA₹-15 Cr₹-5 Cr₹-5 Cr₹-4 Cr₹-5 Cr₹-6 Cr₹-16 Cr₹-146 Cr
Net Profit₹-15 Cr₹-5 Cr₹-6 Cr₹-6 Cr₹-5 Cr₹-7 Cr₹-17 Cr₹-147 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹22 Cr₹34 Cr₹23 Cr₹121 Cr₹18 Cr₹19 Cr₹12 Cr₹8 Cr
EBITDA₹-5 Cr₹-7 Cr₹-3 Cr₹-29 Cr₹-5 Cr₹-6 Cr₹-16 Cr₹-141 Cr
Net Profit₹-5 Cr₹-7 Cr₹-4 Cr₹-32 Cr₹-5 Cr₹-7 Cr₹-17 Cr₹-142 Cr
EPS———-3.74————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2,394 Cr₹2,329 Cr₹2,210 Cr₹1,289 Cr₹1,266 Cr₹995 Cr₹951 Cr₹921 Cr
Total Liabilities₹1,155 Cr₹1,385 Cr₹1,375 Cr₹858 Cr₹902 Cr₹956 Cr₹956 Cr₹956 Cr
Equity₹1,239 Cr₹944 Cr₹835 Cr₹432 Cr₹364 Cr₹39 Cr₹-5 Cr₹-35 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹63 Cr₹437 Cr₹99 Cr₹542 Cr₹28 Cr₹35 Cr₹-24 Cr₹-2 Cr
Investing₹-164 Cr₹-89 Cr₹-196 Cr₹404 Cr₹-16 Cr₹-5 Cr₹28 Cr₹-5 Cr
Financing₹186 Cr₹-338 Cr₹72 Cr₹-1,015 Cr₹-10 Cr₹-34 Cr₹-6 Cr₹5 Cr
Free Cash Flow₹63 Cr₹437 Cr₹100 Cr₹542 Cr₹28 Cr₹35 Cr₹-24 Cr₹-2 Cr
Shareholding
Promoter 7.57% Institutions 1.64% Public 90.78%
Efficiency & Working Capital
ROCE-27.9%
Interest Coverage-9.7
Dividend Payout—
Debtor Days233 d
Inventory Days184 d
Payable Days124 d
Cash Conversion Cycle293 d
Working Capital Days417 d
Shareholding Details

As of 2026-03-31

Promoter7.6%
FII1.6%
DII0%
Institutions1.6%
Public90.8%
Promoter Pledge15.2%
No. of Shareholders47,492
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters20.9%20.9%20.9%20.9%20.9%20.9%20.9%20.9%7.8%7.8%7.8%7.6%
FIIs1.6%1.6%1.6%1.6%1.6%1.6%1.6%1.6%1.6%1.6%1.6%1.6%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public77.4%77.4%77.4%77.4%77.4%77.4%77.4%77.4%90.6%90.6%90.6%90.8%
Promoter Pledge37.1%37.1%37.1%37.1%37.1%37.1%37.1%37.1%14.8%14.8%14.8%15.2%
No. of Shareholders49,50349,03849,02749,01649,01249,00349,00548,95748,92848,92549,22147,492
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Kitara Piin 1102Public Shareholding9.4%77,66,387
Varalwar SandeepShareholding of Promoter and Promoter Group2.8%23,27,632
William F HarveyPublic Shareholding1.7%13,69,840
Sameer Mahendra SampatPublic Shareholding1.6%13,59,165
Subhash VaralwarShareholding of Promoter and Promoter Group1.6%13,49,154
Amicorp Capital (mauritius) LimitedPublic Shareholding1.5%12,19,298
Ashish Bharatkumar ShahPublic Shareholding1.4%11,74,856
Monarch Networth Finserve Private LimitedPublic Shareholding1.2%10,31,000
Jagat Foods Private LimitedPublic Shareholding1.1%9,26,213
Sheetal VaralwarShareholding of Promoter and Promoter Group0.8%6,85,185
Manohar Rao VaralwarShareholding of Promoter and Promoter Group0.5%4,32,174
Bbr Projects Private LimitedShareholding of Promoter and Promoter Group0.5%4,34,450
S RaghunandanShareholding of Promoter and Promoter Group0.4%3,17,500
Madhavi VaralwarShareholding of Promoter and Promoter Group0.2%2,00,000
Mamatha GurnukarShareholding of Promoter and Promoter Group0.2%1,50,000
Vijaykumar VaralwarShareholding of Promoter and Promoter Group0.2%1,50,000
Neelima Vijaya VaralwarShareholding of Promoter and Promoter Group0.1%1,00,000
Chandrashekharrao SudigaliShareholding of Promoter and Promoter Group0.1%50,095
Varalwar PadmaShareholding of Promoter and Promoter Group0%33,250
Sujatha VaralwarShareholding of Promoter and Promoter Group0%25,995
Vithabai VaralwarShareholding of Promoter and Promoter Group0%23,345
Santosh VaralwarShareholding of Promoter and Promoter Group0%0
Satish Gooty AgraharamShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Subhash Varalwar2,99,15422.2%2026-03-31
Varalwar Sandeep79,0003.4%2026-03-31
Manohar Rao Varalwar4,00,00092.6%2026-03-31
Mamatha Gurnukar1,50,000100%2026-03-31
Sujatha Varalwar25,00096.2%2026-03-31
Board of Directors
NameDesignationYear
V Manohar RaoChairman & Wholetime Director2025
Santosh VaralwarExecutive Director & MD2025
Sandeep VaralwarIndependent Non Exe. Director2025
Aparna BidarkarIndependent Non Exe. Director2025
Subbarathnamma PalepUIndependent Non Exe. Director2025
Jarugula Siva PrasadIndependent Non Exe. Director2025
Yugandhar KopparthiCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Speciality Chemicals₹0 Cr0%
Pharma₹108 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2401717
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-17Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025-84103-46-126
2025-94100-46-138
2025500307
Insider / Designated-Person Trades

9 recent disclosure(s)

Santosh VaralwarInvoke · 12,854
SANTOSH VARALWARDisposal · 8,44,542
Sujatha VaralwarInvoke · 15,00,000
Manohar Rao VaralwarInvoke · 2,60,000
Vithabai VaralwarInvoke · 9,50,000
B B R PROJECTS PRIVATE LIMITEDInvoke · 4,31,000
Company Information
Incorporated1988
ChairmanV Manohar Rao
AuditorSVRL & Co
Investor Email[email protected]
🌐 www.vivimedlabs.com ↗

📍 Plot No 78-A, Kolhar Industrial Area, Bidar, Karnataka, 585403

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

JK CementBeeyu Overseas Ltd.Yes BankSPL IndustriesKarnataka Bank Ltd.Facor Alloys Ltd.Rane (Madras) Ltd.HT Media Ltd.Sasken TechnologiesRajvir IndustriesFCS Software SolutionsSuzlon EnergyAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search